Literature DB >> 27587074

Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit.

Andrew J Lautz1, Adam C Dziorny2, Adam R Denson2, Kathleen A O'Connor2, Marianne R Chilutti3, Rachael K Ross4, Jeffrey S Gerber4, Scott L Weiss2.   

Abstract

OBJECTIVES: To determine whether peak blood procalcitonin (PCT) measured within 48 hours of pediatric intensive care unit (PICU) admission can differentiate severe bacterial infections from sterile inflammation and viral infection and identify potential subgroups of PICU patients for whom PCT may not have clinical utility. STUDY
DESIGN: This was a retrospective, observational study of 646 critically ill children who had PCT measured within 48 hours of admission to an urban, academic PICU. Patients were stratified into 6 categories by infection status. We compared test characteristics for peak PCT, C-reactive protein (CRP), white blood cell count (WBC), absolute neutrophil count (ANC), and % immature neutrophils. The area under the receiver operating characteristic curve was determined for each biomarker to discriminate bacterial infection.
RESULTS: The area under the receiver operating characteristic curve was similar for PCT (0.73, 95% CI 0.69, 0.77) and CRP (0.75, 95% CI 0.71, 0.79; P = .36), but both outperformed WBC, ANC, and % immature neutrophils (P < .01 for all pairwise comparisons). The combination of PCT and CRP was no better than either PCT or CRP alone. Diagnostic patterns prone to false-positive and false-negative PCT values were identified.
CONCLUSIONS: Peak blood PCT measured close to PICU admission was not superior to CRP in differentiating severe bacterial infection from viral illness and sterile inflammation; both PCT and CRP outperformed WBC, ANC, and % immature neutrophils. PCT appeared especially prone to inaccuracies in detecting localized bacterial central nervous system infections or bacterial coinfection in acute viral illness causing respiratory failure.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PICU; biomarker; sepsis

Mesh:

Substances:

Year:  2016        PMID: 27587074      PMCID: PMC5217746          DOI: 10.1016/j.jpeds.2016.07.045

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  35 in total

1.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 3.  Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

Authors:  D M Shlaes; D N Gerding; J F John; W A Craig; D L Bornstein; R A Duncan; M R Eckman; W E Farrer; W H Greene; V Lorian; S Levy; J E McGowan; S M Paul; J Ruskin; F C Tenover; C Watanakunakorn
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

Review 4.  Antibiotic de-escalation in the ICU: how is it best done?

Authors:  Jose Garnacho-Montero; Ana Escoresca-Ortega; Esperanza Fernández-Delgado
Journal:  Curr Opin Infect Dis       Date:  2015-04       Impact factor: 4.915

5.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

6.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

Authors:  S Harbarth; K Holeckova; C Froidevaux; D Pittet; B Ricou; G E Grau; L Vadas; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

7.  Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.

Authors:  Juan Casado-Flores; Alfredo Blanco-Quirós; Julia Asensio; Eduardo Arranz; Jose A Garrote; Monserrat Nieto
Journal:  Pediatr Crit Care Med       Date:  2003-04       Impact factor: 3.624

8.  Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.

Authors:  Liliana Simon; Patrick Saint-Louis; Devendra K Amre; Jacques Lacroix; France Gauvin
Journal:  Pediatr Crit Care Med       Date:  2008-07       Impact factor: 3.624

9.  Chart reviews in emergency medicine research: Where are the methods?

Authors:  E H Gilbert; S R Lowenstein; J Koziol-McLain; D C Barta; J Steiner
Journal:  Ann Emerg Med       Date:  1996-03       Impact factor: 5.721

Review 10.  Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.

Authors:  Philipp Schuetz; Werner Albrich; Beat Mueller
Journal:  BMC Med       Date:  2011-09-22       Impact factor: 8.775

View more
  13 in total

1.  Emerging Biomarkers of Illness Severity: Urinary Metabolites Associated with Sepsis and Necrotizing Methicillin-Resistant Staphylococcus aureus Pneumonia.

Authors:  Lilliam Ambroggio; Todd A Florin; Samir S Shah; Richard Ruddy; Larisa Yeomans; Julie Trexel; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2017-07-28       Impact factor: 4.705

Review 2.  Utility of Procalcitonin as a Biomarker for Sepsis in Children.

Authors:  Kevin J Downes; Julie C Fitzgerald; Scott L Weiss
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

3.  Children as Biomarker Orphans: Progress in the Field of Pediatric Biomarkers.

Authors:  Darla R Shores; Allen D Everett
Journal:  J Pediatr       Date:  2017-10-12       Impact factor: 4.406

4.  Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study.

Authors:  Kevin J Downes; Julie C Fitzgerald; Emily Schriver; Craig L K Boge; Michael E Russo; Scott L Weiss; Fran Balamuth; Sherri E Kubis; Pam Tolomeo; Warren B Bilker; Jennifer H Han; Ebbing Lautenbach; Susan E Coffin; Jeffrey S Gerber
Journal:  J Pediatric Infect Dis Soc       Date:  2020-02-28       Impact factor: 3.164

5.  Association of Procalcitonin Value and Bacterial Coinfections in Pediatric Patients With Viral Lower Respiratory Tract Infections Admitted to the Pediatric Intensive Care Unit.

Authors:  John J Kotula; Wayne S Moore; Arun Chopra; Jeffrey J Cies
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Nov-Dec

Review 6.  Sepsis Biomarkers.

Authors:  Hector R Wong
Journal:  J Pediatr Intensive Care       Date:  2019-01-11

Review 7.  Diagnostic Stewardship in the Pediatric Intensive Care Unit.

Authors:  Anna C Sick-Samuels; Charlotte Woods-Hill
Journal:  Infect Dis Clin North Am       Date:  2022-03       Impact factor: 5.982

8.  Diagnostic Errors in Pediatric Critical Care: A Systematic Review.

Authors:  Christina L Cifra; Jason W Custer; Hardeep Singh; James C Fackler
Journal:  Pediatr Crit Care Med       Date:  2021-08-01       Impact factor: 3.971

Review 9.  Consensus Recommendations for Blood Culture Use in Critically Ill Children Using a Modified Delphi Approach.

Authors:  Charlotte Z Woods-Hill; Danielle W Koontz; Annie Voskertchian; Anping Xie; Judy Shea; Marlene R Miller; James C Fackler; Aaron M Milstone
Journal:  Pediatr Crit Care Med       Date:  2021-09-01       Impact factor: 3.971

10.  Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections.

Authors:  Philipp Baumann; Gurli Baer; Jessica Bonhoeffer; Aline Fuchs; Verena Gotta; Ulrich Heininger; Nicole Ritz; Gabor Szinnai; Jan Bonhoeffer
Journal:  Front Pediatr       Date:  2017-08-28       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.